Author: SleepWorld Magazine

Expanding the Sleep Tech Frontier
BRPT Industry News

Expanding the Sleep Tech Frontier

The global field of sleep medicine is at a critical inflection point, and at the heart of it lies a shared challenge—the shortage of qualified sleep technologists. With rising awareness of sleep disorders and their link to chronic health conditions, the demand for structured training and certification has surged, particularly […]

Noctrix Raises $33.5M Expanding Leadership to Accelerate U.S. Commercialization of Nidra(R) Therapy for Restless Legs Syndrome
Restless Leg Syndrome Product/Vendor Updates

Noctrix Health Raises $33.5M, Expands Leadership Team of Nidra Therapy for Restless Legs Syndrome (RLS)

Noctrix Health, Inc., the developer of the Nidra® Tonic Motor Activation (TOMAC) therapy for Restless Legs Syndrome (RLS), announced a significant expansion of private financing to accelerate its U.S. commercial launch. The company also announced several key leadership appointments to strengthen its commercial and scientific teams. Financing Update Noctrix Health […]

Taking the Long View 
Home Sleep Testing (HST) Emerging Technology

Taking the Long View 

Sleep medicine is undergoing a profound transformation. What was once centered around episodic, in-lab evaluations is evolving into a more continuous, personalized model of care.  With the rapid rise of home sleep testing (HST) and increasingly sophisticated wearables, the integration of remote patient monitoring (RPM) into sleep medicine has moved […]

Specific Gut Bacteria Maybe Linked to Insomnia
Insomnia Research/Studies

Specific Gut Bacteria Linked to Insomnia

Specific types of gut bacteria may increase or decrease the risk for insomnia, while insomnia itself may in turn alter the abundance of certain gut bacteria, a new study showed. However, outside experts challenged the investigators’ assertion that the link is causal.  Investigators identified 14 groups of bacteria associated with increased […]

EnsoData and Takeda to Improve Narcolepsy
Narcolepsy Sleep Pharmaceuticals

EnsoData, Takeda to Improve Narcolepsy Type 1 Diagnosis Using AI Tools and Technology

EnsoData has announced a collaboration with Takeda to jointly develop and validate AI-based polysomnography (PSG) algorithms to support more accurate and scalable diagnosis of narcolepsy type 1 (NT1). Upon successful validation and regulatory clearance, EnsoData will pursue the clinical availability and release of AI algorithms to enable future access, use, […]